1.0300
-0.1100
(-9.65%)
At close: January 10 at 4:00:01 PM EST
1.1000
+0.07
+(6.80%)
After hours: 7:26:08 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AJER JEFFREY ROBERT Director | Sale | Sep 18, 2023 | 34,153 |
| CHESS ROBERT BRUCE Director | Sale | Jun 14, 2024 | 261,573 |
| CURET MYRIAM J Director | Sale | Sep 18, 2023 | 27,418 |
| DEEP TRACK CAPITAL LP Beneficial Owner of more than 10% of a Class of Security | Sale | May 10, 2024 | -- |
| ROBIN HOWARD W Chief Executive Officer | Sale | Dec 18, 2024 | 1,111,080 |
| THOMSEN JILLIAN B Chief Financial Officer | Sale | Feb 16, 2023 | 313,497 |
| WHITFIELD ROY ALEC Director | Sale | Jun 14, 2023 | 287,750 |
| WILSON MARK ANDREW Officer | Sale | Dec 24, 2024 | 335,332 |
| ZALEVSKY JONATHAN Officer | Sale | Dec 19, 2024 | 326,904 |
Related Tickers
GOSS Gossamer Bio, Inc.
0.9721
-7.42%
KPTI Karyopharm Therapeutics Inc.
0.7186
+0.36%
AFMD Affimed N.V.
1.1800
-0.84%
SGMO Sangamo Therapeutics, Inc.
1.1650
-4.12%
ACET Adicet Bio, Inc.
0.9171
-4.47%
IVVD Invivyd, Inc.
0.4520
-2.06%
FGEN FibroGen, Inc.
0.6160
-5.35%
AGIO Agios Pharmaceuticals, Inc.
34.42
-4.12%
BLUE bluebird bio, Inc.
8.46
0.00%
FATE Fate Therapeutics, Inc.
1.4650
-12.28%